| Name | Title | Contact Details |
|---|
Our mission is to form long term trusting relationships with healthcare providers to help them deliver outstanding patient outcomes and experiences. We will never compromise quality in creating value through cost-effective healthcare technology solutions. From the services we provide to the equipment and parts we deliver, we will help our customers meet the challenges of providing high quality care while containing cost.
Biomed Resource is a Torrance, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medacta International is a Swiss company developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. Founded in 1999 with a vision to create a better patient experience for people needing joint and spine treatment, Medacta specializes in highly innovative minimally-invasive, personalized approaches designed to bring renewed hope and optimism to patients. Medacta is a recognized leader in Hip Replacement with its proprietary AMIS® (Anterior Minimally Invasive Surgery) product offerings and in Knee Replacement via MyKnee® Patient Matched 3-D printing technology. At the 2014 North American Spine Society (NASS) Annual Meeting, Medacta`s new MySpine® Patient Matched product was awarded "Best New Technology - Posterior Thoracolumbar Spine Treatments".
Schryver Medical is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Based at NASA-Ames Research Center, Scanadu is using mobile and sensor technology to develop a portfolio of FDA approved, consumer friendly products that put the experience of an emergency room in the palm of your hand. Unveiled in November 2012, the company is working to ensure this is the last generation to know so little about our health. The product portfolio includes the Scanadu Scout vital sign monitor and Scanadu Urine, a urine analysis test. In July 2013, Scanadu became the most funded campaign on Indiegogo, enlisting supporters to be a part of the first usability study, followed by clinical studies for the company’s road to FDA approval.